246521-91-5

Upstream product

• 501-53-1 benzyl chloroformate 
• 246521-90-4 (4R,5R)-2-[4-(benzyloxy)phenyl]-4-(azidomethyl)-5-vinyl-1,3-oxazoline 
• 246521-89-1 (4R,5R)-2-[4-(benzyloxy)phenyl]-4-(hydroxymethyl)-5-vinyl-1,3-oxazoline 
• 246521-88-0 (4R,5R)-2-[4-(benzyloxy)phenyl]-4-[(tert-butyldimethylsilanyloxy)methyl]-5-vinyl-1,3-oxazoline 

Downstream Products

• 246521-92-6 (4R,5R)-4-(allylbenzyloxycarbonylaminomethyl)-2-[4-(benzyloxy)phenyl]-5-vinyl-1,3-oxazoline 
• 246521-94-8 C₂₈H₂₈N₂O₄ 
• 246521-95-9 (-)-4-(benzyloxy)phenyl [(3R,4R)-1-(benzyloxy)-carbonyl-2,3,4,7-tetrahydro-4-hydroxy-1H-azepin-3-yl]carbamate 
• 246521-93-7 C₂₈H₂₆N₂O₄ 
• 158584-98-6 4-hydroxy-3-[4-(phenylmethoxy)benzoylamino]-1-(phenylmethoxycarbonyl)-hexahydroazepine 

Relevant academic research and scientific papers

Asymmetric synthesis of the balanol heterocycle via a palladium-mediated epimerization and olefin metathesis.

[formula: see text] The enantioselective formal synthesis of balanol, a potent protein kinase C inhibitor, was accomplished from D-serine utilizing a Pd-catalyzed equilibration of diastereomeric 5-vinyloxazolines to set the stereochemistry of the vicinal